alpha-methyl-m-tyrosine

RN given refers to cpd without stereoisomeric designation; structure in Merck Index, 9th ed, #6004

Also Known As:

alpha-methyl-m-tyrosine, (DL)-isomer; alpha-methyl-m-tyrosine, (L)-isomer; alpha-methyl-meta-tyrosine

Networked: 5 relevant articles (1 outcomes, 0 trials/studies)

1.	Ventricular Fibrillation 01/01/1987 - "Depletion of myocardial NA stores with alpha-methyl-meta-tyrosine (alpha-MmT) caused a significant reduction in both the incidence of ventricular fibrillation and the mortality rate after left coronary artery ligation in anesthetized rats. "
2.	Cardiac Arrhythmias (Arrythmia) 03/01/1970 - "Ouabain-induced arrhythmia in the rabbit: effects of alpha-methyl-meta-tyrosine." 01/01/1968 - "Effects of alpha-methyl-meta-tyrosine on ouabain-induced ventricular arrhythmia in the rabbit."
3.	Seizures (Absence Seizure) 11/01/1989 - "Moreover, alpha-methyltyrosine, and alpha-methyl-m-tyrosine also lowered metrazol threshold seizures, but had no effect on brain alpha-aminobutyric acid contents. "
4.	Hypothermia 06/01/1975 - "Pre-treatment of rats with 6-hydroxydopamine, alpha-methyl-m-tyrosine or haloperidol significantly antagonized the cocaine hypothermia. "

1.	2-methylcyclopentadienyl manganese tricarbonyl (MMT)
2.	Ouabain (G Strophanthin)
3.	alpha-Methyltyrosine (Metirosine)
4.	Oxidopamine (6 Hydroxydopamine)
5.	Pentylenetetrazole (Metrazol)
6.	Haloperidol (Haldol)
7.	Cocaine (Cocaine HCl)
8.	alpha-aminobutyric acid

1.	Ligation